Cargando…
Kruppel-Like Factor 15 Is Critical for the Development of Left Ventricular Hypertrophy
Left ventricular hypertrophy (LVH) is an independent risk factor for adverse cardiovascular events and is often present in patients with hypertension. Treatment to reduce blood pressure and regress LVH is key to improving health outcomes, but currently available drugs have only modest cardioprotecti...
Autores principales: | Patel, Sheila K., Ramchand, Jay, Crocitti, Vincenzo, Burrell, Louise M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983718/ https://www.ncbi.nlm.nih.gov/pubmed/29702551 http://dx.doi.org/10.3390/ijms19051303 |
Ejemplares similares
-
Left ventricular hypertrophy in experimental chronic kidney disease is associated with reduced expression of cardiac Kruppel-like factor 15
por: Patel, Sheila K., et al.
Publicado: (2018) -
Genetic Variation in Kruppel like Factor 15 Is Associated with Left Ventricular Hypertrophy in Patients with Type 2 Diabetes: Discovery and Replication Cohorts
por: Patel, Sheila K., et al.
Publicado: (2017) -
Does Krüppel Like Factor 15 Play an Important Role in the Left Ventricular Hypertrophy of Patients with Type 2 Diabetes?
por: Zhao, Yuguang, et al.
Publicado: (2017) -
Does left ventricular hypertrophy affect cognition and brain structural integrity in type 2 diabetes? Study design and rationale of the Diabetes and Dementia (D2) study
por: Patel, Sheila K., et al.
Publicado: (2017) -
Kruppel-like factor 15 induces the development of mature hepatocyte-like cells from hepatoblasts
por: Anzai, Kazuya, et al.
Publicado: (2021)